Alkem Laboratories Share Price, Stock Analysis & Company Profile

Alkem Laboratories Ltd is a leading Indian pharmaceutical company engaged in the development, manufacturing, and marketing of branded generics, generic drugs, and active pharmaceutical ingredients (APIs). The company has a strong presence in both domestic and international markets, making it a key player in India’s pharmaceutical sector.

This page serves as a comprehensive resource for investors to track the Alkem Laboratories share price on the NSE and BSE, along with essential data required for a detailed Alkem Laboratories stock analysis.

Stay updated with broader pharmaceuticals & drugs sector trends and benchmark Alkem Laboratories' movement against the overall market - Check market data and sector performance now.

About Alkem Laboratories Ltd

Founded in 1973 by Samprada Singh, Alkem Laboratories Ltd is headquartered in Mumbai, Maharashtra. The company started as a domestic pharmaceutical player and has grown into a globally recognised pharma company with operations across more than 50 countries.

Alkem has established a strong foothold in the Indian branded generics market, particularly in therapeutic segments such as anti-infectives, gastroenterology, pain management, and vitamins. Internationally, the company has a growing presence in the United States, where it operates in the generics segment.

The company operates multiple manufacturing facilities that comply with global regulatory standards, including approvals from the US FDA and other international regulatory bodies. Its focus on research and development has enabled it to expand its product portfolio and strengthen its competitive positioning.

Alkem Laboratories Business Model

Alkem Laboratories follows a diversified pharmaceutical business model with multiple revenue streams:

• Retail / Branded Generics (India): A major contributor to revenue, Alkem has a strong domestic franchise with well-established brands prescribed by healthcare professionals across key therapeutic segments.
   
• International Business: The company exports generic formulations and APIs to markets such as the US, Europe, and emerging economies, diversifying geographic risk.
   
• Active Pharmaceutical Ingredients (APIs): Manufactures APIs for captive consumption as well as third-party sales, ensuring better cost control and supply chain integration.
   
• Contract Manufacturing & Institutional Sales: Supplies medicines to government bodies, hospitals, and global institutions through tenders and partnerships.
   
• Research & Development: Invests in R&D for complex generics, ANDA filings, and product innovation, which supports long-term growth and regulatory approvals in global markets.

Diversify beyond a single PSU bank stock like IOB with curated portfolios - Discover ready-made stock bundles tailored to your goals.

Alkem Laboratories Listing and IPO Details

Alkem Laboratories Ltd is listed on both major Indian stock exchanges and is widely tracked among pharmaceutical sector stocks.

NSE Symbol: ALKEM

BSE Scrip Code: 539523

Face Value: Rs 2 per share

ISIN: INE540L01014

Sector Status: 

Alkem Laboratories operates in the pharmaceuticals & drugs sector and is analysed based on its domestic brand strength, US generics performance, and regulatory compliance.

Track upcoming IPO opportunities similar to PSU banking investments - Browse the latest IPO listings and details today.

Alkem Laboratories Corporate Action History

Alkem Laboratories has maintained a balanced approach towards shareholder returns and business reinvestment.

Stock Split History

The company has maintained a consistent capital structure and has not frequently undertaken stock splits in recent years.

Dividend History

Alkem Laboratories has a track record of paying dividends, reflecting stable cash flows and profitability.

FY 2023-24: Declared a healthy dividend, supported by steady domestic growth and improved margins.

FY 2022-23: Maintained consistent dividend payouts despite global pricing pressure in the generics segment.

Note: Dividend decisions depend on earnings visibility, R&D investments, and capital allocation priorities.

Investor Resources Available on This Page

On this page, investors can access key financial and operational data for a structured Alkem Laboratories stock analysis:

• Price Chart: Track the latest trends and historical performance of the Alkem Laboratories share price (data delayed by 15 minutes).
   
• Company Ratios: Evaluate key metrics such as Return on Equity (ROE), EBITDA margins, and Earnings Per Share (EPS).
  Identify stocks with similar financial metrics as IOB using advanced filters - Start screening stocks via using the Finology Screener based on your criteria now.
   
• Quarterly Results: Analyse revenue growth, net profit trends, segment performance, and margin expansion.
   
• Balance Sheet & Cash Flow: Review debt levels, working capital efficiency, and cash generation.
   
• Shareholding Pattern: Track promoter holdings along with institutional and retail investor participation.
   
• Pros & Cons: Quick insights into strengths such as strong domestic brands versus risks like US pricing pressure and regulatory challenges.
   
• Annual Reports: Download official annual reports and investor disclosures directly from the Reports Section on this page.

Strengthen your investment decisions with structured learning and tools - Access the top investors' resources and insights now.

Frequently Asked Questions

Q1. What is the latest Alkem Laboratories share price?

The current share price is displayed at the top of this page. Data from NSE and BSE may be delayed by up to 15 minutes.

Q2. What does Alkem Laboratories do?

Alkem Laboratories is a pharmaceutical company that manufactures and markets branded generics, generic drugs, and APIs across domestic and international markets.

Q3. Does Alkem Laboratories pay dividends?

Yes, Alkem Laboratories has a consistent dividend-paying track record, subject to profitability and capital allocation strategy.

Q4. What is the face value of Alkem Laboratories shares?

The face value of each equity share of Alkem Laboratories Ltd is Rs 2.

Q5. Is Alkem Laboratories a good long-term investment?

Alkem Laboratories is considered a strong player in the pharma sector due to its domestic leadership and global expansion. However, factors such as regulatory risks and pricing pressure in export markets should be considered.

Q6. Where can I find the latest Alkem Laboratories Annual Report?

You can access the latest annual reports and financial disclosures from the Reports or Documents section available on this page.

Q7. What are ANDA filings and why are they important for Alkem?

ANDA (Abbreviated New Drug Application) filings allow the company to market generic drugs in the US. For Alkem, successful approvals are crucial for expanding its international revenue and improving margins.